Air pollution exposure, both before and after birth, significantly escalates the risk of respiratory infections in children.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Children under 5 with RSV or flu face higher bacteremia risk if febrile, under 6 months, or need respiratory support, with ...

While you are soaking up the summer sun, doctors say you can still get sick, including from two new COVID strains that are ...

While you are soaking up the summer sun, doctors say you can still get sick, including from two new COVID strains that are ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

These findings suggest that, although the upper respiratory tract may serve as a primary source for microbiota in the lower respiratory tract, the relative abundances of taxa across different ...

The role of innate immune system in respiratory viral infection related asthma Provisionally accepted Xiao Wu 1,2 Feifei Huang 1,2 Wenbo Yao 3* Xue Zheng 1,2* ...

ENFLONSIA is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in ...

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) ...

About ENFLONSIA™ (clesrovimab-cfor) ENFLONSIA is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial virus (RSV) lower ...